13FPulse
RE

REPL REPLIMUNE GROUP INC

2026Q2 · CUSIP 76029N106 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
197
Institutions that reported holding it to the SEC
Net increase in holders
+18
Last quarter 179 → now 197
How unusual is that
Top 20%
Stronger buying than 81% of US stocks
What the filings say, in one paragraph

197 funds held REPL at the end of 2026Q2, up 18 from the quarter before. That is stronger buying than 81.4% of US stocks — among the most piled-into names this quarter. On the business itself, return on equity is -281.1%. REPL has had 4 buying rushes in its history, and the price moved +21.5% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2018Q4: holders=50 2019Q1: holders=53 2019Q2: holders=52 2019Q3: holders=50 2019Q4: holders=60 2020Q1: holders=55 2020Q2: holders=76 2020Q3: holders=77 2020Q4: holders=110 2021Q1: holders=108 2021Q2: holders=109 2021Q3: holders=100 2021Q4: holders=98 2022Q1: holders=105 2022Q2: holders=101 2022Q3: holders=105 2022Q4: holders=136 2023Q1: holders=139 2023Q2: holders=141 2023Q3: holders=127 2023Q4: holders=140 2024Q1: holders=150 2024Q2: holders=149 2024Q3: holders=143 2024Q4: holders=157 2025Q1: holders=165 2025Q2: holders=174 2025Q3: holders=162 2025Q4: holders=165 2026Q1: holders=179 2026Q2: holders=197 -33 -16.5 +0 +16.5 +33 45126207 18Q419Q320Q221Q121Q422Q323Q224Q124Q425Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 4 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 20%
2022Q4 Top 20% -27.6% -19.0%
2020Q4 Top 20% -15.7% -5.5%
2020Q2 Top 20% +0.4% +89.0%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
97
Change in large funds
+6
Total value they hold
$1.1B
Funds buying for the first time
73
Funds that sold out entirely
55
Price change that quarter
+212.8%
Funds holding puts (bearish)
14
Funds holding calls (bullish)
12

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-3.15
EPS YoY
Revenue (TTM)
Revenue YoY
Net margin
ROE
-281.1%
Debt ratio
58.1%
FCF (TTM)
-$281M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.56 2021-12-31: EPS -0.57 2022-03-31: EPS -0.60 2022-06-30: EPS -0.78 2022-09-30: EPS -0.79 2022-12-31: EPS -0.69 2023-03-31: EPS -0.73 2023-06-30: EPS -0.75 2023-09-30: EPS -0.90 2023-12-31: EPS -0.77 2024-03-31: EPS -0.82 2024-06-30: EPS -0.78 2024-09-30: EPS -0.68 2024-12-31: EPS -0.79 2025-03-31: EPS -0.82 2025-06-30: EPS -0.95 2025-09-30: EPS -0.90 2025-12-31: EPS -0.77 2026-03-31: EPS -0.76 2026-06-30: EPS -0.72 -1.04 -0.52 0.00 20212022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-83M-41M0K 2017201820192020202120222023202420252026
Latest quarter $-56M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.